• AI
  • Molecular Imaging
  • CT
  • X-Ray
  • Ultrasound
  • MRI
  • Facility Management
  • Mammography

3D firm buys tumor-imaging tech

Article

Medical Media Systems has purchased the assets of GHRL, a Cambridge, MA, provider of validated industry-standard technology for 3D imaging of tumors. As part of the purchasing agreement, the West Lebanon, NH, provider of remote 3D medical imaging and

Medical Media Systems has purchased the assets of GHRL, a Cambridge, MA, provider of validated industry-standard technology for 3D imaging of tumors. As part of the purchasing agreement, the West Lebanon, NH, provider of remote 3D medical imaging and treatment planning applications will also sponsor a National Cancer Institute-funded clinical study to examine whether tumor volume is a better indicator of changes in tumor size and growth than the 2D-based RECIST (response evaluation criteria in solid tumors) protocol that measures the longest diameters of target lesions. The retrospective study, scheduled to begin in early 2004, will be conducted with the Dana Farber Cancer Institute and Harvard Medical School-affiliated hospitals.

Recent Videos
2 KOLs are featured in this series.
2 KOLs are featured in this series.
2 KOLs are featured in this series.
2 KOLs are featured in this series.
Detecting PCa Recurrence in African Americans: Can 18F-Flotufolastat Have an Impact?
Emerging Research at SNMMI Examines 18F-flotufolastat in Managing Primary and Recurrent Prostate Cancer
Could Pluvicto Have a Role in Taxane-Naïve mCRPC?: An Interview with Oliver Sartor, MD
New SNMMI President Cathy Cutler, PhD, Discusses Current Challenges and Goals for Nuclear Medicine
Where the USPSTF Breast Cancer Screening Recommendations Fall Short: An Interview with Stacy Smith-Foley, MD
A Closer Look at MRI-Guided Transurethral Ultrasound Ablation for Intermediate Risk Prostate Cancer
Related Content
© 2024 MJH Life Sciences

All rights reserved.